About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rb1tm1Brd
targeted mutation 1, Allan Bradley
MGI:1857339
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Rb1tm1Brd/Rb1tm1Brd involves: 129S7/SvEvBrd * C57BL/6 MGI:2169820
ht2
Rb1tm1Brd/Rb1+ involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J MGI:3834166
ht3
Rb1tm1Brd/Rb1+ involves: 129S7/SvEvBrd * C57BL/6 MGI:2684728
cx4
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1+
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J MGI:3834164
cx5
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1tm1Brd
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J MGI:3834165
cx6
Rb1tm1Brd/Rb1+
Rr70tm1Alb/Rr70+
involves: 129S7/SvEvBrd * C57BL/6 MGI:3717490
cx7
Rb1tm1Brd/Rb1+
Trp53tm1Brd/Trp53+
involves: 129S7/SvEvBrd * C57BL/6J MGI:3834167


Genotype
MGI:2169820
hm1
Allelic
Composition
Rb1tm1Brd/Rb1tm1Brd
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1Brd mutation (0 available); any Rb1 mutation (111 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• no homozygous mutant embryos are identified after E16
• notably, transfer of a human retinoblastoma mini-transgene rescues the lethal phenotype; homozygotes harboring multiple copies of this mini-transgene are viable and some reach the age of 6 months displaying no obvious neuronal or hematopoietic system defects

nervous system
• at E11.5, homozygotes display massive neuronal apoptosis throughout the CNS, esp. in the hindbrain region; telencephalic structures and caudal spinal cord are less affected
• at E12.5, mutant embryos show extensive cell death in the intermediate zone and maturing neuronal centers; the ventricular zone of the spinal cord appears relatively unaffected
• although most brain regions develop on time, the cytoarchitecture of mutant brains is distorted
• in homozygotes, the overall size of the developing brain is reduced relative to wild-type
• by E12.5, many homozygotes have an enlarged fourth ventricle
• at E13.5, the spinal cord and spinal ganglia of mutant embryos exhibit ectopic mitosis and neuronal cell death; as a result, the size of mutant spinal ganglia is markedly reduced by E15.5
• as early as E11.5, mutant dorsal root ganglia exhibit extensive cell death; by 15.5, these ganglia are reduced to small sheath-like structures

hematopoietic system
• at E14.5 and at E15.5, many of the nucleated erythrocytes in mutant embryos show aberrant morphology and staining
• although hepatic hematopoiesis occurs in mutant embryos, most of the erythrocytes are of the less mature, nucleated type
• in E12.5 mutant embryos, ~75% of the total erythrocyte population in peripheral blood is nucleated as in wild-type embryos; however, nucleated erythrocytes still present 65% of the population at E13.5, 70% at E14.5 and 50% at E15.5, suggesting deregulated proliferation of mutant primitive erythrocytes

liver/biliary system
• at E14.5 and at E15.5, mutant livers display enlarged sinusoids relative to wild-type
• at E14.5 and at E15.5, mutant livers have fewer hepatocytes relative to wild-type
• at E14.5 and at E15.5, the mutant liver is smaller but hematopoietic islands are clearly identifiable

embryo
• homozygotes appear morphologically normal up to E10.5
• notably, by E11.5, ~30% of mutant embryos appear developmentally abnormal relative to wild-type; the time of onset of abnormalities varies over a 2-3 day period

growth/size/body
• all homozygotes become runted by E14.0

cardiovascular system
• by E13.5, many homozygotes are pale with poor blood distribution
• at E14.5 and at E15.5, mutant livers display enlarged sinusoids relative to wild-type

homeostasis/metabolism
• by E12.5, many homozygotes appear distorted by swelling

skeleton
• by E13.5, >79% of homozygotes display a characteristic hunchback appearance

cellular
• at E11.5, homozygotes display massive neuronal apoptosis throughout the CNS, esp. in the hindbrain region; telencephalic structures and caudal spinal cord are less affected
• at E12.5, mutant embryos show extensive cell death in the intermediate zone and maturing neuronal centers; the ventricular zone of the spinal cord appears relatively unaffected
• at E12.5, homozygotes display abundant mitotic figures in CNS regions normally reserved for neuronal migration or differentiation (e.g. the ventricular zone and intermediate zone of the spinal cord)
• ectopic cells divisions are also detected in the developing inferior olive, which appears wider and less organized; however, no significant cell death is observed concomitant with a 30% increase in the number of migrating cells

vision/eye
N
• surprisingly, mutant retinas display normal size and cytoarchitecture relative to wild-type
• no signs of cell loss are observed in the developing neural retinas up to E15.5




Genotype
MGI:3834166
ht2
Allelic
Composition
Rb1tm1Brd/Rb1+
Genetic
Background
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1Brd mutation (0 available); any Rb1 mutation (111 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• some mice develop tumors of the pituitary anterior lobe
• all mice develop melanotroph tumors of the pituitary
• most mice develop C cell thyroid carcinomas

nervous system
• some mice develop tumors of the pituitary anterior lobe
• all mice develop melanotroph tumors of the pituitary

endocrine/exocrine glands
• some mice develop tumors of the pituitary anterior lobe
• all mice develop melanotroph tumors of the pituitary
• most mice develop C cell thyroid carcinomas




Genotype
MGI:2684728
ht3
Allelic
Composition
Rb1tm1Brd/Rb1+
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1Brd mutation (0 available); any Rb1 mutation (111 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• surprisingly, none of >100 heterozygotes studied show any macroscopic signs of retinoblastoma relative to wild-type mice (J:2516)
• survival of 65 diet restricted heterozygous males is almost identical to that of 67 heterozygous males fed ad libitum (J:79648)
• surprisingly, 40-50% reductions in dietary intake, relative to an ad libitum group, initiated on either P28 or P42 have minimal to no effect on either the frequency or growth of pituitary tumors either during the latency period (P224) or at the time of natural death (J:79648)
• at >8 months of age, 90% of heterozygotes display signs of pituitary tumors as a "wasting" syndrome; both sexes are susceptible to tumor development
• in young heterozygotes, foci of anaplasia or micro-tumors arise from the intermediate lobe and outgrow toward the neuronal lobe of pituitary glands
• multiple foci are frequently observed in the tiny intermediate lobe of the pituitary gland; on average, 2.2. tumors devepo per intermediate lobe
• in heterozygotes, tumor tissues invariably lose expression of full-length protein due to loss of the remaining wild-type allele
• in heterozygotes, tumor incidence increases with age, with a 21% predisposition at the age of <6 months, >50% at 6-8 months, and 100% at 10 months; the earliest tumor was detected at 2 months
• at an advanced stage, pituitary tumors often infiltrate other tissues e.g. hypothalamus, optic nerved, pons, cerebellum, third ventricle, meninges and subarachnoid space
• distal metastasis to the cervical lymph nodes and spinal cord is also detected
• heterozygotes develop brain tumors at the ages of 4, 7, 8 and 12 months; such tumors are found to arise from cells in which the wild-type allele is absent

endocrine/exocrine glands
• in heterozygotes, tumor cells appear to exhibit phenotypes of neuroendocrine cells (neuroendocrine neoplasia)
• at >8 months of age, 90% of heterozygotes display signs of pituitary tumors as a "wasting" syndrome; both sexes are susceptible to tumor development
• in young heterozygotes, foci of anaplasia or micro-tumors arise from the intermediate lobe and outgrow toward the neuronal lobe of pituitary glands
• multiple foci are frequently observed in the tiny intermediate lobe of the pituitary gland; on average, 2.2. tumors devepo per intermediate lobe
• in heterozygotes, tumor tissues invariably lose expression of full-length protein due to loss of the remaining wild-type allele
• in heterozygotes, tumor incidence increases with age, with a 21% predisposition at the age of <6 months, >50% at 6-8 months, and 100% at 10 months; the earliest tumor was detected at 2 months

growth/size/body
• heterozygotes exhibit a 10% increase in body mass relative to wild-type; although this change is reproducible, no excess accumulation of fat is observed
• heterozygotes bearing large pituitary tumors (~7 mm in diameter) exhibit a severe wasting syndrome
• ~3% of tumor-bearing heterozygotes are obese, probably as a result of elevated ACTH levels

nervous system
• at >8 months of age, 90% of heterozygotes display signs of pituitary tumors as a "wasting" syndrome; both sexes are susceptible to tumor development
• in young heterozygotes, foci of anaplasia or micro-tumors arise from the intermediate lobe and outgrow toward the neuronal lobe of pituitary glands
• multiple foci are frequently observed in the tiny intermediate lobe of the pituitary gland; on average, 2.2. tumors devepo per intermediate lobe
• in heterozygotes, tumor tissues invariably lose expression of full-length protein due to loss of the remaining wild-type allele
• in heterozygotes, tumor incidence increases with age, with a 21% predisposition at the age of <6 months, >50% at 6-8 months, and 100% at 10 months; the earliest tumor was detected at 2 months
• heterozygotes develop brain tumors at the ages of 4, 7, 8 and 12 months; such tumors are found to arise from cells in which the wild-type allele is absent




Genotype
MGI:3834164
cx4
Allelic
Composition
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1+
Genetic
Background
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Msh2tm1Whl mutation (0 available); any Msh2 mutation (95 available)
Rb1tm1Brd mutation (0 available); any Rb1 mutation (111 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• life span is extended compared to mice homozygous for the Msh2 allele alone but shorter than that of mice heterozygous for the Rb allele alone

neoplasm
• microsatellite instability is seen in all lymphomas and intestinal tumors but not in other tumor types
• some mice develop soft tissue tumors (myxoid fibrosarcoma, hemangiosarcoma, and hemangioendothelioma)
• most mice develop gastrointestinal tumors
• some mice develop tumors of the pituitary anterior lobe
• all mice develop melanotroph tumors of the pituitary
• apoptosis of lymphoma cells is increased compared to cells from mice homozygous for the Msh2 allele alone
• most mice develop C cell thyroid carcinomas

hematopoietic system
• apoptosis of lymphoma cells is increased compared to cells from mice homozygous for the Msh2 allele alone
• ability of hematopoietic cells to rescue lethally irradiated mice is impaired although not as badly as for cells from double homozygous mice

integument

digestive/alimentary system
• most mice develop gastrointestinal tumors

endocrine/exocrine glands
• some mice develop tumors of the pituitary anterior lobe
• all mice develop melanotroph tumors of the pituitary
• apoptosis of lymphoma cells is increased compared to cells from mice homozygous for the Msh2 allele alone
• most mice develop C cell thyroid carcinomas

nervous system
• some mice develop tumors of the pituitary anterior lobe
• all mice develop melanotroph tumors of the pituitary

immune system
• apoptosis of lymphoma cells is increased compared to cells from mice homozygous for the Msh2 allele alone




Genotype
MGI:3834165
cx5
Allelic
Composition
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1tm1Brd
Genetic
Background
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Msh2tm1Whl mutation (0 available); any Msh2 mutation (95 available)
Rb1tm1Brd mutation (0 available); any Rb1 mutation (111 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• ability of hematopoietic cells to rescue lethally irradiated mice is impaired




Genotype
MGI:3717490
cx6
Allelic
Composition
Rb1tm1Brd/Rb1+
Rr70tm1Alb/Rr70+
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1Brd mutation (0 available); any Rb1 mutation (111 available)
Rr70tm1Alb mutation (0 available); any Rr70 mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• 7 of 10 mice lack correct DNA methylation patterns




Genotype
MGI:3834167
cx7
Allelic
Composition
Rb1tm1Brd/Rb1+
Trp53tm1Brd/Trp53+
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rb1tm1Brd mutation (0 available); any Rb1 mutation (111 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (240 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• life span is shorter compared to littermates with only a single gene defect





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory